Roles of Solar UVB and Vitamin D in Reducing Cancer Risk and Increasing Survival.

The present article reviews existing scientific evidence in support of the ultraviolet-B (UVB)-vitamin D-cancer hypothesis, now being in its 35th year. Literature evidence comes from geographical ecological and observational studies, two successful clinical trials, and an understanding of how vitamin D reduces risk of and increases survival from cancer. Each approach has its strengths and limitations, and considering findings from all of these approaches yields the best conclusions. There exist over 15 types of cancer for which UVB exposure and/or 25-hydroxyvitamin D [25(OH)D] concentrations have been found associated with reduced risk. The optimal 25(OH)D concentration for preventing and surviving cancer appears to be above 75-100 nmol/l. There exists mounting evidence that individuals with higher 25(OH)D concentration at the time of cancer diagnosis have better cancer-specific and overall survival rates, suggesting that cancer-affected people should raise their 25(OH)D concentrations.

[1]  H. Putter,et al.  Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01). , 2016, Breast.

[2]  S. Gandini,et al.  Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[3]  K. He,et al.  Vitamin D supplementation and quality of life following diagnosis in stage II colorectal cancer patients: a 24-month prospective study , 2016, Supportive Care in Cancer.

[4]  G. Scagliotti,et al.  Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy , 2015, Chronobiology international.

[5]  Ling Wang,et al.  Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose–response meta-analysis , 2015, Cancer Causes & Control.

[6]  A. Jemal,et al.  Cancer death rates in US congressional districts , 2015, CA: a cancer journal for clinicians.

[7]  M. La Guardia,et al.  Vitamin D in cancer chemoprevention , 2015, Pharmaceutical biology.

[8]  P. Webb,et al.  Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer. , 2015, The American journal of clinical nutrition.

[9]  M. Holick,et al.  Sunlight and Vitamin D: Necessary for Public Health , 2015, Journal of the American College of Nutrition.

[10]  M. Johansson,et al.  Circulating 25-Hydroxyvitamin D3 and Survival after Diagnosis with Kidney Cancer , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[11]  E. Bonifacio,et al.  Widespread seasonal gene expression reveals annual differences in human immunity and physiology , 2015, Nature Communications.

[12]  Liqun Zhang,et al.  Vitamin D and Lung Cancer Risk: A Comprehensive Review and Meta-Analysis , 2015, Cellular Physiology and Biochemistry.

[13]  R. Gascoyne,et al.  Lifetime Physical Activity and the Risk of Non-Hodgkin Lymphoma , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[14]  M. Berridge Vitamin D cell signalling in health and disease. , 2015, Biochemical and biophysical research communications.

[15]  S. Mohr,et al.  Could vitamin D sufficiency improve the survival of colorectal cancer patients? , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  Yangang Wang,et al.  Serum 25-Hydroxyvitamin D Levels and Prognosis in Hematological Malignancies: A Systematic Review and Meta-Analysis , 2015, Cellular Physiology and Biochemistry.

[17]  M. Wanner,et al.  Associations between objective and self-reported physical activity and vitamin D serum levels in the US population , 2015, Cancer Causes & Control.

[18]  J. Mursu,et al.  The association between serum 25-hydroxyvitamin D3 concentration and risk of disease death in men: modification by magnesium intake , 2015, European Journal of Epidemiology.

[19]  J. Craig,et al.  Vitamin D and cancer mortality in elderly women , 2015, BMC Cancer.

[20]  Min‐ge Xie,et al.  Temporal Relationship between Vitamin D Status and Parathyroid Hormone in the United States , 2015, PloS one.

[21]  D. Sjoberg,et al.  Serum 25-Hydroxy Vitamin D and Survival in Advanced Colorectal Cancer: A Retrospective Analysis , 2015, Nutrition and cancer.

[22]  W. Grant 25-hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case-control versus nested case-control studies. , 2015, Anticancer research.

[23]  S. Glück,et al.  Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. , 2015, Clinical breast cancer.

[24]  F. D. de Gruijl,et al.  UV exposure inhibits intestinal tumor growth and progression to malignancy in intestine‐specific Apc mutant mice kept on low vitamin D diet , 2015, International journal of cancer.

[25]  Zhiping Yan,et al.  Meta-analysis of prospective cohort studies of cigarette smoking and the incidence of colon and rectal cancers , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[26]  L. Dušek,et al.  Time-course pattern of blood 25-hydroxycholecalciferol is a significant predictor of survival outcome in metastatic colorectal cancer: a clinical practice-based study. , 2015, Neoplasma.

[27]  M. Tomíška,et al.  [Vitamin D during cancer treatment]. , 2015, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

[28]  J. Reichrath,et al.  Low Serum 25-Hydroxyvitamin D Concentrations Are Associated with Increased Risk for Melanoma and Unfavourable Prognosis , 2014, PloS one.

[29]  S. Gandini,et al.  BsmI polymorphism of vitamin D receptor gene and cancer risk: a comprehensive meta-analysis. , 2014, Mutation research.

[30]  E. Riboli,et al.  Original Contribution Circulating 25-Hydroxyvitamin D3 in Relation to Renal Cell Carcinoma Incidence and Survival in the EPIC Cohort , 2014 .

[31]  S. Gandini,et al.  Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysis. , 2014, Carcinogenesis.

[32]  Jie Jin,et al.  Vitamin D status and risk of non-Hodgkin lymphoma: a meta-analysis , 2014, Cancer Causes & Control.

[33]  A. Tenesa,et al.  Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  E. Giovannucci,et al.  Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. , 2014, American journal of public health.

[35]  M. Murad,et al.  Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis , 2014, BMC Gastroenterology.

[36]  Zhaofen Lin,et al.  Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis , 2014, Journal of Cancer Research and Clinical Oncology.

[37]  Jing-quan Li,et al.  Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. , 2014, The Journal of clinical endocrinology and metabolism.

[38]  T. Tan,et al.  The role of vitamin D in skeletal and cardiac muscle function , 2014, Front. Physiol..

[39]  O. Franco,et al.  Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies , 2014, BMJ : British Medical Journal.

[40]  G. Colditz,et al.  Circulating 25-hydroxyvitamin D Levels and Prognosis among Cancer Patients: A Systematic Review , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[41]  J. Meyerhardt,et al.  Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. , 2014, The American journal of clinical nutrition.

[42]  Xiao-hui Liu,et al.  Recurrence season impacts the survival of epithelial ovarian cancer patients. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[43]  I. Çiçin,et al.  Medical treatment of breast cancer bone metastasis: from bisphosphonates to targeted drugs. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[44]  M. Holick,et al.  Vitamin D and inflammation , 2014, Dermato-endocrinology.

[45]  E. Giovannucci,et al.  Vitamin D status and cancer incidence and mortality. , 2014, Advances in experimental medicine and biology.

[46]  M. Holick,et al.  From rickets prophylaxis to general preventive healthcare , 2014 .

[47]  R. Heaney Guidelines for optimizing design and analysis of clinical studies of nutrient effects. , 2014, Nutrition reviews.

[48]  P. Autier,et al.  Vitamin D status and ill health: a systematic review. , 2014, The lancet. Diabetes & endocrinology.

[49]  B. Henderson,et al.  Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case–control study in the multiethnic cohort study , 2014, BMC Cancer.

[50]  W. Grant A Multicountry Ecological Study of Cancer Incidence Rates in 2008 with Respect to Various Risk-Modifying Factors , 2013, Nutrients.

[51]  Lin Fritschi,et al.  Association between ultraviolet radiation, skin sun sensitivity and risk of pancreatic cancer. , 2013, Cancer epidemiology.

[52]  P. Brennan,et al.  Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis. , 2013, Blood.

[53]  S. Tretli,et al.  The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation , 2013, Cancers.

[54]  D. Miao,et al.  1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. , 2013, Current medicinal chemistry.

[55]  W. Grant,et al.  Molecular Link between Vitamin D and Cancer Prevention , 2013, Nutrients.

[56]  K. Osteen,et al.  Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. , 2013, Human reproduction.

[57]  R. Herr,et al.  A systematic review of vitamin D status in populations worldwide , 2013, British Journal of Nutrition.

[58]  Stefan Pilz,et al.  Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. , 2013, Autoimmunity reviews.

[59]  M. Holick,et al.  Vitamin D for health: a global perspective. , 2013, Mayo Clinic proceedings.

[60]  Dan Wang,et al.  Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies , 2013, Tumor Biology.

[61]  J. Pierce,et al.  Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project , 2013, Breast Cancer Research and Treatment.

[62]  J. Manson,et al.  Blood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes , 2013, Diabetes Care.

[63]  Relationship between cancer survival and ambient ultraviolet B irradiance in China , 2013, Cancer Causes & Control.

[64]  H. Brenner,et al.  Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. , 2013, The American journal of clinical nutrition.

[65]  H. Brenner,et al.  Strong associations of 25-hydroxyvitamin D levels with all-cause, cardiovascular, cancer and respiratory disease mortality in a large cohort study , 2013 .

[66]  A. Sigurdson,et al.  Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. , 2013, Anticancer research.

[67]  N. Núñez,et al.  Using components of the vitamin D pathway to prevent and treat colon cancer. , 2012, Nutrition reviews.

[68]  J. Manson,et al.  Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.

[69]  R. Lucas,et al.  Association between Ambient Ultraviolet Radiation and Risk of Epithelial Ovarian Cancer , 2012, Cancer Prevention Research.

[70]  R. Lucas,et al.  Association Between Ambient Ultraviolet Radiation and Risk of Esophageal Cancer , 2012, The American Journal of Gastroenterology.

[71]  Serk In Park,et al.  The multifaceted actions of PTHrP in skeletal metastasis. , 2012, Future oncology.

[72]  I. Romieu,et al.  Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case–control study in Mexican women , 2012, Cancer Causes & Control.

[73]  M. Fenech,et al.  Does vitamin D protect against DNA damage? , 2012, Mutation research.

[74]  Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma , 2012, Cancer Causes & Control.

[75]  E. Garrett-Mayer,et al.  Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. , 2012, The Journal of clinical endocrinology and metabolism.

[76]  W. Grant Role of solar UVB irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordic countries , 2012, Dermato-endocrinology.

[77]  W. Grant,et al.  Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans , 2012, Dermato-endocrinology.

[78]  W. Grant,et al.  Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate , 2012, Dermato-endocrinology.

[79]  C. Macera,et al.  Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria? , 2012, Dermato-endocrinology.

[80]  K. Pienta,et al.  Disrupting the Networks of Cancer , 2012, Clinical Cancer Research.

[81]  W. Grant Ultraviolet exposure and non-Hodgkin’s lymphoma: beneficial and adverse effects? , 2012, Cancer Causes & Control.

[82]  Fenghua Wang,et al.  Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer , 2012, Journal of Translational Medicine.

[83]  S. Tretli,et al.  Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study , 2011, Cancer Causes and Control.

[84]  J. Manson,et al.  Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[85]  I. Reid,et al.  Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. , 2011, The American journal of clinical nutrition.

[86]  C. Macera,et al.  Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. , 2011, Anticancer research.

[87]  L. Bernstein,et al.  Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study. , 2011, Blood.

[88]  J. Knight,et al.  Ultraviolet sunlight exposure during adolescence and adulthood and breast cancer risk: a population-based case-control study among Ontario women. , 2011, American journal of epidemiology.

[89]  N. Prevarskaya,et al.  Calcium in tumour metastasis: new roles for known actors , 2011, Nature Reviews Cancer.

[90]  W. Grant Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level; implications for meta-analyses and setting vitamin D guidelines , 2011, Dermato-endocrinology.

[91]  Dean P. Jones,et al.  Effects of Supplemental Vitamin D and Calcium on Biomarkers of Inflammation in Colorectal Adenoma Patients: A Randomized, Controlled Clinical Trial , 2011, Cancer Prevention Research.

[92]  H. Adami,et al.  Prospective Study of UV Exposure and Cancer Incidence Among Swedish Women , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[93]  K. Dear,et al.  The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[94]  M. Stampfer,et al.  Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer , 2011, PloS one.

[95]  A. Adjei,et al.  Dietary vitamin D intake and serum 25‐hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients , 2011, International journal of cancer.

[96]  G. Byrnes,et al.  Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma , 2011, International journal of cancer.

[97]  Kai Yu,et al.  Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men. , 2011, American journal of epidemiology.

[98]  J. L. Smith Serum 25-Hydroxyvitamin D3 Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma , 2011 .

[99]  G. Friedrich,et al.  Vitamin D status is associated with disease-free survival and overall survival time in patients with squamous cell carcinoma of the upper aerodigestive tract , 2011, European Archives of Oto-Rhino-Laryngology.

[100]  B. Alexander,et al.  Multiple indicators of ambient and personal ultraviolet radiation exposure and risk of non-Hodgkin lymphoma (United States). , 2010, Journal of photochemistry and photobiology. B, Biology.

[101]  F. Clavel-Chapelon,et al.  Joint Effects of Dietary Vitamin D and Sun Exposure on Breast Cancer Risk: Results from the French E3N Cohort , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[102]  Brigid M Lynch,et al.  State of the epidemiological evidence on physical activity and cancer prevention. , 2010, European journal of cancer.

[103]  K. Helzlsouer American Journal of Epidemiology Original Contribution Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2022 .

[104]  Wanqing Chen,et al.  Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China , 2010, Cancer Causes & Control.

[105]  W. Grant An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production , 2010, Dermato-endocrinology.

[106]  G. Dranitsaris,et al.  A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases , 2010, Cancer.

[107]  J. Barrett,et al.  Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[108]  G. P. Studzinski,et al.  Vitamin D and differentiation in cancer , 2009, Critical reviews in clinical laboratory sciences.

[109]  J. Koivukangas,et al.  Season of tumor surgery in relation to deaths among brain tumor patients: does sunlight and month of surgery play a role in brain tumor deaths? , 2009, Acta Neurochirurgica.

[110]  S. Mohr,et al.  Vitamin D for cancer prevention: global perspective. , 2009, Annals of epidemiology.

[111]  H. Olsson,et al.  A population-based cohort study on sun habits and endometrial cancer , 2009, British Journal of Cancer.

[112]  M. Tisdale Mechanisms of cancer cachexia. , 2009, Physiological reviews.

[113]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[114]  R. Hayes,et al.  Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. , 2009, Cancer research.

[115]  W. Grant How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill’s criteria for causality , 2009, Dermato-endocrinology.

[116]  Pär Sparén,et al.  Occupation and cancer – follow-up of 15 million people in five Nordic countries , 2009, Acta oncologica.

[117]  J. Knight,et al.  Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. , 2008, American journal of epidemiology.

[118]  K. Fearon Cancer cachexia: developing multimodal therapy for a multidimensional problem. , 2008, European journal of cancer.

[119]  A. Schatzkin,et al.  Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study , 2008, Cancer Causes & Control.

[120]  J. Cerhan,et al.  Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium , 2008, International journal of cancer.

[121]  R. Recker,et al.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.

[122]  E. John,et al.  Sun Exposure and Prostate Cancer Risk: Evidence for a Protective Effect of Early-Life Exposure , 2007, Cancer Epidemiology Biomarkers & Prevention.

[123]  J. Moan,et al.  Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: A possible role of sun-induced Vitamin D , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[124]  E. Hyppönen,et al.  Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. , 2007, The American journal of clinical nutrition.

[125]  W. Grant An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking , 2006, International journal of cancer.

[126]  Francis P Boscoe,et al.  Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002 , 2006, BMC Cancer.

[127]  D. Albanes,et al.  A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. , 2006, Cancer research.

[128]  J. Peto,et al.  Cancer survival is dependent on season of diagnosis and sunlight exposure , 2006, International journal of cancer.

[129]  Majid Ezzati,et al.  Eight Americas: Investigating Mortality Disparities across Races, Counties, and Race-Counties in the United States , 2006, PLoS medicine.

[130]  W. Grant,et al.  The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. , 2006, Anticancer research.

[131]  Yan Liu,et al.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.

[132]  Martin Lipkin,et al.  The role of vitamin D in cancer prevention. , 2006, American journal of public health.

[133]  J. Moan,et al.  Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D , 2005, British Journal of Cancer.

[134]  S. Kato,et al.  1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. , 2005, Carcinogenesis.

[135]  A. Astbury Cancer mortality in the USA and cosmic ray neutron dosage , 2005 .

[136]  J. Kaldor,et al.  Sun exposure may protect against non‐Hodgkin lymphoma: A case‐control study , 2004, International journal of cancer.

[137]  T. Mizoue ECOLOGICAL STUDY OF SOLAR RADIATION AND CANCER MORTALITY IN JAPAN , 2004, Health physics.

[138]  S. Kato,et al.  1α, 25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer , 2004 .

[139]  Johan Moan,et al.  Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway) , 2004, Cancer Causes & Control.

[140]  D. Zehnder,et al.  Vitamin D‐Mediated Hypercalcemia in Lymphoma: Evidence for Hormone Production by Tumor‐Adjacent Macrophages , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[141]  A. Howie,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Extrarenal Expression of 25-Hydroxyvitamin , 2022 .

[142]  D. Weed,et al.  Causal criteria in nutritional epidemiology. , 1999, The American journal of clinical nutrition.

[143]  D. Leffell,et al.  Sunlight and skin cancer. , 1996, Scientific American.

[144]  E. Takahashi Stomach cancer and ecologic factors in Japan. , 1974, The Tohoku journal of experimental medicine.

[145]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.